Evidence map›Paper›PMID 35982187›Full record

ArticleScientific reports2022

Computational simulation of liver fibrosis dynamics.

Misa Yoshizawa, Masahiro Sugimoto, Minoru Tanaka, Yusuyuki Sakai, Masaki Nishikawa

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Lumped parameter modeling of changes in liver hemodynamics due to cirrhosis.Biomechanics and modeling in mechanobiology · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. The 3Rs in Experimental Liver Disease.Animals : an open access journal from MDPI · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Misa YoshizawaDepartment of Chemical System Engineering, University of Tokyo, Tokyo, Japan.
Masahiro SugimotoInstitute of Medical Science, Tokyo Medical University, 6-1-1, Shinjuku, Tokyo, 160-0022, Japan. mshrsgmt@tokyo-med.ac.jp.ORCID 0000-0003-3316-2543
Minoru TanakaDepartment of Regenerative Medicine, Research Institute, National Centre for Global Health and Medicine, Tokyo, Japan.
Yusuyuki SakaiDepartment of Chemical System Engineering, University of Tokyo, Tokyo, Japan.
Masaki NishikawaDepartment of Chemical System Engineering, University of Tokyo, Tokyo, Japan.
The University of Tokyo · JPNational Center for Global Health and Medicine · JPTokyo Medical University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Liver fibrosis is a result of homeostasis breakdown caused by repetitive injury. The accumulation of collagens disrupts liver structure and function, which causes serious consequences such as cirrhosis. Various mathematical simulation models have been developed to understand these complex processes. We employed the agent-based modelling (ABM) approach and implemented inflammatory processes in central venous regions. Collagens were individually modelled and visualised depending on their origin: myofibroblast and portal fibroblast. Our simulation showed that the administration of toxic compounds induced accumulation of myofibroblast-derived collagens in central venous regions and portal fibroblast-derived collagens in portal areas. Subsequently, these collagens were bridged between central-central areas and spread all over areas. We confirmed the consistent dynamic behaviour of collagen formulation in our simulation and from histological sections obtained via in vivo experiments. Sensitivity analyses identified dead hepatocytes caused by inflammation and the ratio of residential liver cells functioned as a cornerstone for the initiation and progression of liver fibrosis. The validated mathematical model demonstrated here shows virtual experiments that are complementary to biological experiments, which contribute to understanding a new mechanism of liver fibrosis.

Indexed as

LiverLiver CirrhosisCollagenFibrosisHepatocytesHumansMyofibroblastsCollagen

Identifiers

PMID35982187
PMCPMC9388486
OpenAlexW4298280860

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.